AI Bias Analysis
4 models · Takes ~15 seconds
Alnylam announced a three-year deal with Inceptive Nucleics, worth up to $2 billion, with $30 million upfront in cash and equity in the startup.
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- The FDA approved the Titan Prime inflatable penile prosthesis for men with erectile dysfunction, Coloplast announced on Wednesday. This prosthesis is indicated for men who are considered to be candidates for implantation of...
(MedPage Today) -- Patients highly sensitized to HLA successfully underwent kidney transplantation after desensitization with the use of dual chimeric antigen receptor (CAR) T-cell therapy. In a safety run-in cohort of an ongoing phase I trial...
(MedPage Today) -- The name of a condition that affects between 6-10% of all reproductive-age women was recently changed from PCOS (polycystic ovary syndrome) to PMOS (polyendocrine metabolic ovarian syndrome) by an international consensus process...
Highmark Health is the fourth insurer to sue HaloMD, seeking to overturn arbitration wins.
